First Previous 1 2 3 

Rushikesh's Updates (35)

• 
• The Population Health Management Market, valued at USD 71.83 billion in 2023, is poised for significant expansion in the coming years. Projections indicate a substantial surge, with expectations set at reaching USD 352.55 billion by 2031. This anticipated growth is underpinned by a robust compound annual growth rate (CAGR) of 22.07% throughout the forecast period spanning from 2024 to 2031. As healthcare systems worldwide increasingly prioritize proactive approaches to improving health... [more]

   Health,  May 20, 2024

  0 reply
• 
• The Blood Screening Market, estimated at USD 3.02 billion in 2023, is on track for substantial growth in the years ahead. Forecasts suggest a robust upward trajectory, with projections indicating a rise to USD 7.37 billion by 2031. This anticipated expansion is underpinned by a strong compound annual growth rate (CAGR) of 11.8% throughout the forecast period from 2024 to 2031. As the importance of blood screening in healthcare systems worldwide continues to grow, driven by factors such as the... [more]

   Health,  May 20, 2024

  0 reply
• 
• The Diabetes Devices Market, with an estimated size of USD 29.1 billion in 2022, stands poised for substantial growth in the coming years. Projections indicate a robust upward trajectory, with expectations set at reaching USD 53.06 billion by 2030. This anticipated expansion is driven by a strong compound annual growth rate (CAGR) of 7.8% throughout the forecast period spanning from 2023 to 2030. As diabetes continues to be a prevalent global health concern, the demand for innovative devices... [more]

   Health,  May 20, 2024

  0 reply
• 
• The Respiratory Syncytial Virus (RSV) Therapeutics Market exhibited substantial growth, with a valuation of USD 5.75 billion in 2023, as reported by recent data. Projections suggest a remarkable upward trajectory, with expectations indicating a surge to USD 15.28 billion by 2031. This anticipated expansion reflects a robust compound annual growth rate (CAGR) of 13% over the forecast period spanning from 2024 to 2031. Such promising figures underscore the growing importance and demand for... [more]

   Health,  May 20, 2024

  0 reply
• 
• According to insights from SNS INSIDER, the Pharma 4.0 Market demonstrated substantial growth, reaching a valuation of 12.80 billion in 2023. Looking ahead, the market is poised for even greater expansion, with projections indicating it will surge to 39.60 billion by 2031. This trajectory suggests a robust compound annual growth rate (CAGR) of 17.5% over the forecast period spanning from 2024 to 2031. Such promising figures underscore the dynamic evolution and significant potential within the... [more]

   Health,  May 20, 2024

  0 reply